52 studies found for:    Open Studies | "Adenoviridae Infections"
Show Display Options
Rank Status Study
21 Unknown  Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Interventions: Biological: Recombinant DNA- pVAX/L523S;   Biological: Recombinant adenovirus- Ad/L523S
22 Recruiting A Phase 1 Ascending Dose Study to Assess the Safety and Immunogenicity of Adenovirus Anthrax Vector Candidate Vaccines
Condition: Anthrax Infection
Interventions: Biological: AVA;   Biological: Ad4-PA-1;   Biological: Ad4-PA-GPI-1
23 Recruiting Safety Study of Adenovirus Vector Engineered to Express hIL-12 (Human Interleukin 12) in Combination With Activator Ligand to Treat Melanoma
Condition: Unresectable Stage III or IV Melanoma
Interventions: Biological: INXN-2001;   Drug: INXN-1001
24 Unknown  A Pilot Study of Filtrum-STI in Children With Viral Gastroenteritis
Condition: Viral Gastroenteritis
Interventions: Drug: Filtrum-STI (lignin hydrolytic);   Drug: Placebo
25 Recruiting IMPACT Canadian Rotavirus Surveillance of Hospitalizations and Emergency Department Visits
Condition: Viral Gastroenteritis Due to Rotavirus
Intervention:
26 Recruiting Anti-virus Treatment Following Bone Marrow Transplant
Conditions: Allogeneic Stem Cell Transplant;   Viral Infection;   Viral Reactivation
Intervention: Biological: Viral specific CTL Infusion
27 Recruiting Multivirus-specific T Cells for the Treatment of Virus Infections After Stem Cell Transplant
Condition: Infection
Intervention: Biological: Multivirus Specific T cells
28 Recruiting ADenoVirus Initiative Study in Epidemiology in France
Condition: Viral Conjunctivitis
Intervention:
29 Recruiting ADenoVirus Initiative Study in Epidemiology in Germany
Condition: Viral Conjunctivitis
Intervention:
30 Not yet recruiting ADenoVirus Initiative Study in Epidemiology in UK
Condition: Viral Conjunctivitis
Intervention:
31 Not yet recruiting Study of a Recombinant Adenovirus to Treat Localized Prostate Cancer
Condition: Localized Prostate Cancer
Intervention: Drug: Ad5-SGE-REIC/Dkk3
32 Recruiting Intranasal AD4-H5-VTN as an Adenovirus Vaccine
Condition: Healthy Volunteer
Intervention: Biological: Ad4-H5-Vtn
33 Unknown  Trial of E10A in Head and Neck Cancer
Conditions: Head and Neck Squamous Carcinoma;   Nasopharyngeal Carcinoma
Interventions: Drug: E10A;   Drug: Cisplatin;   Drug: Paclitaxel
34 Recruiting A Phase I Dose Escalation Study of Intravenous VCN-01 With or Without Gemcitabine in Patients With Advanced Solid Tumors
Conditions: Locally Advanced Solid Tumors;   Metastatic Solid Tumors
Interventions: Genetic: VCN-01;   Drug: Gemcitabine
35 Recruiting A Phase I Dose Escalation Study of Intratumoral VCN-01 Injections With or Without Gemcitabine in Patients With Advanced Pancreatic Cancer
Conditions: Locally Advanced Pancreatic Adenocarcinoma;   Metastatic Pancreatic Adenocarcinoma
Interventions: Genetic: VCN-01;   Drug: Gemcitabine
36 Recruiting Virus DNX2401 and Temozolomide in Recurrent Glioblastoma
Conditions: Glioblastoma Multiforme;   Recurrent Tumor
Intervention: Procedure: DNX2401 and Temozolomide
37 Unknown  Study of Treatment and Metabolism in Patients With Urea Cycle Disorders
Condition: Amino Acid Metabolism, Inborn Errors
Interventions: Behavioral: Protein and calorie controlled diet;   Genetic: Ornithine transcarbamylase vector
38 Recruiting Mechanism of Action Trial of ColoAd1
Condition: Resectable Colon Cancer
Intervention: Biological: Colo-Ad1
39 Recruiting Phase I Study of Ad5-hGCC (Human Guanylyl Cyclase C)-PADRE in Stage I/II Colon Cancer
Condition: Colon Cancer
Intervention: Biological: Ad5-hGCC-PADRE vaccine
40 Not yet recruiting Administration of AdVEGF-All6A+ to Myocardium of Individuals With Diffuse CAD Via Minimally Invasive Surgery
Condition: Coronary Artery Disease
Interventions: Biological: AdVEGF-All6A+;   Biological: AdNull

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-52) Show next page of results
Indicates status has not been verified in more than two years